Wen Wee Ma Selected Research

Wen Wee Ma Research Topics

Disease

28	Neoplasms (Cancer) 03/2022 - 09/2008
17	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 12/2010
12	Adenocarcinoma 03/2022 - 12/2010
4	Fatigue 01/2022 - 12/2010
4	Neutropenia 10/2013 - 09/2008
3	Disease Progression 03/2021 - 10/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2013
3	Exanthema (Rash) 09/2017 - 08/2013
3	Nausea 01/2017 - 08/2013
3	Diarrhea 01/2017 - 08/2013
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 02/2015
2	Vomiting 01/2017 - 10/2016
2	Mucositis 01/2017 - 09/2008
2	Melanoma (Melanoma, Malignant) 10/2016 - 02/2015
1	Thrombocytopenia 3 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Glioma (Gliomas) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 12/2017
1	Pathologic Complete Response 12/2017
1	Turcot syndrome 05/2017
1	Adenoid Cystic Carcinoma (Cylindroma) 03/2017
1	Cardiotoxicity 01/2017
1	Leukopenia 01/2017
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2017
1	Edema (Dropsy) 10/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2013
1	Infections 10/2013

Drug/Important Bio-Agent (IBA)

11	Gemcitabine FDA Link 12/2021 - 04/2012
5	Capecitabine (Xeloda)FDA Link 01/2019 - 12/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2013
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 08/2013
3	Pharmaceutical PreparationsIBA 11/2019 - 10/2013
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 12/2010
3	EnzymesIBA 01/2017 - 12/2010
3	130-nm albumin-bound paclitaxelIBA 07/2016 - 10/2013
2	Immune Checkpoint InhibitorsIBA 03/2022 - 05/2017
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2021 - 01/2013
2	sonidegibIBA 11/2019 - 01/2019
2	Cetuximab (Erbitux)FDA Link 11/2019 - 01/2013
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 04/2015
2	Sorafenib (BAY 43-9006)FDA Link 02/2015 - 02/2015
2	pazopanib FDA Link 08/2013 - 08/2013
1	Dosage Forms (Dosage Form)IBA 01/2022
1	methanesulfonic acid (methanesulfonate)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Lomustine (CCNU)FDA Link 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 12/2021
1	Anaplastic Lymphoma KinaseIBA 12/2021
1	Proto-Oncogene Proteins c-metIBA 12/2021
1	ceritinibIBA 12/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	BilirubinIBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	AntibodiesIBA 11/2019
1	Growth Factor ReceptorsIBA 11/2019
1	Drug CombinationsIBA 11/2019
1	LigandsIBA 01/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2019
1	Smoothened ReceptorIBA 01/2019
1	HhAntag691IBA 01/2019
1	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 01/2018
1	CotinineIBA 09/2017
1	Nicotine FDA Link 09/2017
1	Somatomedin Receptors (Somatomedin Receptor)IBA 03/2017
1	dacomitinibIBA 03/2017
1	figitumumabIBA 03/2017
1	uridine triacetateIBA 01/2017
1	cobimetinibIBA 10/2016
1	Drug CarriersIBA 01/2016
1	Liposomes (Liposome)IBA 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	VaccinesIBA 08/2015
1	Algenpantucel-LIBA 08/2015
1	LY2334737IBA 04/2015
1	ProdrugsIBA 04/2015
1	ARQ 197IBA 02/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2015
1	entinostat (MS 275)IBA 02/2015
1	Histone Deacetylase InhibitorsIBA 02/2015
1	Albumin-Bound Paclitaxel FDA Link 10/2013
1	Biological ProductsIBA 10/2013
1	AlbuminsIBA 10/2013
1	Pemetrexed (MTA)FDA Link 08/2013

Therapy/Procedure

18	Therapeutics 03/2022 - 09/2011
11	Drug Therapy (Chemotherapy) 03/2022 - 08/2015
5	Neoadjuvant Therapy 03/2022 - 12/2017
3	Immunotherapy 01/2020 - 08/2015
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 06/2012
1	Immunomodulation 01/2022
1	Oral Administration 01/2022
1	Adjuvant Chemotherapy 12/2017
1	Chemoradiotherapy 08/2015